Disclosure Of First-Time Adoption [Text Block]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
22,019,000 NOK
8,899,000 NOK
39,087,000 NOK
52,696,000 NOK
122,702,000 NOK
127,476,000 NOK
189,234,000 NOK
854,000 NOK
268,869,000 NOK
46,987,000 NOK
88,498,000 NOK
35,780,000 NOK
0 NOK
8,866,000 NOK
43,852,000 NOK
Comprehensive income
0 NOK
0 NOK
140,531,000 NOK
140,531,000 NOK
0 NOK
189,234,000 NOK
189,234,000 NOK
0 NOK
0 NOK
0 NOK
Profit (loss)
139,282,000 NOK
139,282,000 NOK
190,401,000 NOK
190,401,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.